393 related articles for article (PubMed ID: 31376037)
1. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
Tang L; Ishikawa Y; Matsushita H; Jingu K
Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
[TBL] [Abstract][Full Text] [Related]
3. Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors.
Yi M; Lin H; Bedrosian I; Shen Y; Hunt KK; Chavez-MacGregor M; King TA; Mittendorf EA
Ann Surg Oncol; 2020 Feb; 27(2):359-366. PubMed ID: 31667721
[TBL] [Abstract][Full Text] [Related]
4. [The 8th edition of the American Joint Committee on Cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients].
Sun GY; Wang SL; Tang Y; Yang Y; Fang H; Wang JY; Jing H; Zhang JH; Jin J; Song YW; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Wang WH; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):615-623. PubMed ID: 31434454
[No Abstract] [Full Text] [Related]
5. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
6. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
[TBL] [Abstract][Full Text] [Related]
7. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
Zhou B; Xu L; Ye J; Xin L; Duan X; Liu Y
Anticancer Res; 2017 Aug; 37(8):4615-4621. PubMed ID: 28739761
[TBL] [Abstract][Full Text] [Related]
9. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
10. Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection.
Park S; Choi S; Cho YA; Sinn DH; Kim JM; Park CK; Ha SY
Cancer Res Treat; 2020 Oct; 52(4):1145-1152. PubMed ID: 32599989
[TBL] [Abstract][Full Text] [Related]
11. Risk of Recurrence in Differentiated Thyroid Cancer: A Population-Based Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems.
Gan T; Huang B; Chen Q; Sinner HF; Lee CY; Sloan DA; Randle RW
Ann Surg Oncol; 2019 Sep; 26(9):2703-2710. PubMed ID: 30830539
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
Lombardi A; Vitale V; Nigri G; Olivieri C; Mastrangeli MR; Bizzaglia E; Amanti C
Breast J; 2020 Jul; 26(7):1265-1269. PubMed ID: 32180300
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making.
Lian CL; Li GQ; Zhou P; Wang J; He ZY; Wu SG
Breast; 2021 Oct; 59():117-123. PubMed ID: 34229126
[TBL] [Abstract][Full Text] [Related]
14. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.
Kang J; Lee HP; Kim HR; Kim JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Ryu JS; Cho KJ; Lee MY; Kim SB; Kim YH; Park SR
Surg Oncol; 2020 Dec; 35():491-497. PubMed ID: 33130441
[TBL] [Abstract][Full Text] [Related]
15. AJCC 8th Edition oral cavity squamous cell carcinoma staging - Is it an improvement on the AJCC 7th Edition?
Pollaers K; Hinton-Bayre A; Friedland PL; Farah CS
Oral Oncol; 2018 Jul; 82():23-28. PubMed ID: 29909897
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
17. Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting.
Wong RX; Wong FY; Lim J; Lian WX; Yap YS
Breast; 2018 Aug; 40():38-44. PubMed ID: 29677569
[TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of ypTNM Stage Grouping in the 8th Edition of the American Joint Committee on Cancer TNM Staging System for Esophageal Squamous Cell Carcinoma.
Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
Ann Surg Oncol; 2021 Feb; 28(2):650-660. PubMed ID: 33025354
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
[TBL] [Abstract][Full Text] [Related]
20. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
